Elos Medtech Nomination Committee appointed ahead of Annual General Meeting 2016

In accordance with resolutions passed at the Annual General Meeting in 2015, the Elos Medtech Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of August, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder.

When appointing the Nomination Committee, the rules of the Swedish Code of Corporate Governance (the Code) are to be observed, which entail, inter alia, that no member of company management may be a member of the Nomination Committee, that Board members are not to constitute a majority of the Committee and that no more than one constituent Board member of the Committee may be dependent in relation to any of the company’s major shareholders.

In accordance with resolutions passed at the Annual General Meeting in 2015, the following members of the Nomination Committee of Elos Medtech AB have been appointed:

-       Thomas Öster, appointed by the Öster family
-       Ulf Runmarker, appointed by the Runmarker family
-       Bo Nilsson, appointed by the Nilsson family
-       Bengt Belfrage, appointed by Nordea Fonder
-       Stig-Arne Blom, Chairman of the Board
The Nomination Committee’s chairman is Bengt Belfrage, appointed by the Nomination Committee.
The Nomination Committee jointly represents approximately 66% of the voting rights for all vote-carrying shares in the company.

The Annual General Meeting of Elos Medtech AB will be held on Monday, 26 April 2016

The Nomination Committee is to submit proposals regarding the following issues for approval by the 2016 Annual General Meeting:
-       Election of Chairman of the Meeting
-       Number of Board Directors
-       Fees for the Board of Directors, Chairman of the Board and remuneration for committee work
-       Election of Directors of the Board and Chairman of the Board
-       Fees for the auditors
-       Election of auditors
-       Tasks and principles for the Nomination Committee

Shareholders who wish to submit proposals to the Elos Medtech Nomination Committee, may e-mail valberedning@elosmedtech.com under the heading “to the Nomination Committee” or send a letter by post to Elos Medtech AB, Nya Stadens Torg 10, SE-531 31 Lidköping, marked “to the Nomination Committee”, no later than 15 January 2016.

Lidköping, 26 October 2015

Elos Medtech AB (publ)

For further information, please contact: Bengt Belfrage, Chairman of the Nomination Committee, telephone 46 (0)705 16 32 45, E-post bengt@belfrage.se

The information in this press release is such that Elos Medtech AB is obligated to publish in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was issued for publication on 26 October 2015, at 13:00 a.m. (CET).

For additional information visit www.elosmedtech.com 


About Us

Elos Medtech is one of the leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental , Orthopedics and Life Science. Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.